GRAIL is a leader in innovating new technologies to improve cancer screening. Dedicated to easing the global struggle against cancer, GRAIL uses advanced DNA sequencing, conducts extensive clinical studies, and employs cutting-edge technology—all aligned to help detect deadly cancers. At GRAIL, scientists, engineers, and physicians unite to screen for multiple cancer types and facilitate collaboration to adopt new technologies that can transform cancer screening. Learn about the Galleri® multi-cancer early detection test offered by GRAIL. Visit GRAIL.com or Galleri.com for more information.